☰

Ashley Cannon, Ph.D. - Publications

Affiliations: 
2012 Molecular Neuroscience College of Medicine - Mayo Clinic 
Area:
Neuropathology of aging, dementia and parkinsonism
Tree Info Grants Similar researchers PubMed Report error

28 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Assia Batzir N, Kishor Bhagwat P, Larson A, Coban Akdemir Z, Bagłaj M, Bofferding L, Bosanko KB, Bouassida S, Callewaert B, Cannon A, Enchautegui Colon Y, Garnica AD, Harr MH, Heck S, Hurst AC, et al. Recurrent Arginine Substitutions in the ACTG2 Gene are the Primary Driver of Disease Burden and Severity in Visceral Myopathy. Human Mutation. PMID 31769566 DOI: 10.1002/Humu.23960  0.331
2015 Murray ME, Lowe VJ, Graff-Radford NR, Liesinger AM, Cannon A, Przybelski SA, Rawal B, Parisi JE, Petersen RC, Kantarci K, Ross OA, Duara R, Knopman DS, Jack CR, Dickson DW. Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer's disease spectrum. Brain : a Journal of Neurology. 138: 1370-81. PMID 25805643 DOI: 10.1093/Brain/Awv050  0.582
2014 Cannon A, Bieniek KF, Lin WL, Notari S, Zou WQ, Gambetti P, Pedraza O, Graff-Radford NR, Ferman TJ, Dickson DW. Concurrent variably protease-sensitive prionopathy and amyotrophic lateral sclerosis. Acta Neuropathologica. 128: 313-5. PMID 24928712 DOI: 10.1007/S00401-014-1309-8  0.711
2014 Murray ME, Cannon A, Graff-Radford NR, Liesinger AM, Rutherford NJ, Ross OA, Duara R, Carrasquillo MM, Rademakers R, Dickson DW. Differential clinicopathologic and genetic features of late-onset amnestic dementias. Acta Neuropathologica. 128: 411-21. PMID 24899141 DOI: 10.1007/S00401-014-1302-2  0.569
2014 D'Alton S, Altshuler M, Cannon A, Dickson DW, Petrucelli L, Lewis J. Divergent phenotypes in mutant TDP-43 transgenic mice highlight potential confounds in TDP-43 transgenic modeling. Plos One. 9: e86513. PMID 24466128 DOI: 10.1371/Journal.Pone.0086513  0.761
2013 Rutherford NJ, Lewis J, Clippinger AK, Thomas MA, Adamson J, Cruz PE, Cannon A, Xu G, Golde TE, Shaw G, Borchelt DR, Giasson BI. Unbiased screen reveals ubiquilin-1 and -2 highly associated with huntingtin inclusions. Brain Research. 1524: 62-73. PMID 23774650 DOI: 10.1016/J.Brainres.2013.06.006  0.613
2013 Clippinger AK, D'Alton S, Lin WL, Gendron TF, Howard J, Borchelt DR, Cannon A, Carlomagno Y, Chakrabarty P, Cook C, Golde TE, Levites Y, Ranum L, Schultheis PJ, Xu G, et al. Robust cytoplasmic accumulation of phosphorylated TDP-43 in transgenic models of tauopathy. Acta Neuropathologica. 126: 39-50. PMID 23666556 DOI: 10.1007/S00401-013-1123-8  0.755
2013 Cannon A, Fujioka S, Rutherford NJ, Ferman TJ, Broderick DF, Boylan KB, Graff-Radford NR, Uitti RJ, Rademakers R, Wszolek ZK, Dickson DW. Clinicopathologic variability of the GRN A9D mutation, including amyotrophic lateral sclerosis. Neurology. 80: 1771-7. PMID 23596077 DOI: 10.1212/Wnl.0B013E3182919059  0.481
2012 Cannon A, Yang B, Knight J, Farnham IM, Zhang Y, Wuertzer CA, D'Alton S, Lin WL, Castanedes-Casey M, Rousseau L, Scott B, Jurasic M, Howard J, Yu X, Bailey R, et al. Neuronal sensitivity to TDP-43 overexpression is dependent on timing of induction. Acta Neuropathologica. 123: 807-23. PMID 22539017 DOI: 10.1007/S00401-012-0979-3  0.754
2012 Bailey R, Cannon A, Melrose H, Farrer M, Dickson D, Lewis J. P1-195: LRRK2 modulation of neuropathology in a mouse model of tauopathy Alzheimer's & Dementia. 8: P175-P175. DOI: 10.1016/J.Jalz.2012.05.473  0.685
2012 Lewis J, Cannon A, D'Alton S, Dickson DW, Petrucelli L. S5-02-02: Lessons learned from emerging mouse models of TDP-43 proteinopathy Alzheimer's & Dementia. 8: P725-P725. DOI: 10.1016/J.Jalz.2012.05.1949  0.714
2012 D'Alton S, Altshuler M, Cannon A, Dickson D, Petrucelli L, Lewis J. O4-07-06: Influence on phenotype of the postnatal developmental period in mice expressing human M337V TDP-43 Alzheimer's & Dementia. 8: P628-P629. DOI: 10.1016/J.Jalz.2012.05.1676  0.732
2011 Abisambra J, Cannon A, O'Leary J, Brady S, Espinosa A, Jinwal U, Koren J, Blair L, Lewis J, Dickey C. O4-04-08: Neuronal tau-specific stress induction of molecular chaperones: The failure of a coping mechanism Alzheimer's & Dementia. 7: S691-S691. DOI: 10.1016/J.Jalz.2011.05.1996  0.577
2011 Cannon A, Yang B, Knight J, Farnham M, Zhang Y, Wuertzer C, D'Alton S, Howard J, Lin W, Scott B, Jurasic M, Yu X, Bailey R, Dickson D, Petrucelli L, et al. P3-006: Neurons during early development are highly vulnerable to TDP-43 dysregulation Alzheimer's & Dementia. 7: S517-S517. DOI: 10.1016/J.Jalz.2011.05.1445  0.724
2010 Lewis J, Xu Y, Cannon A, Zhang Y, Lin W, Hutton M, McGowan E, Dickson DW, Petrucelli L. O1-04-04: TDP-43 mouse models: Tools toward understanding the normal and disease roles for TDP-43 Alzheimer's & Dementia. 6: S77-S77. DOI: 10.1016/J.Jalz.2010.05.228  0.678
2008 Sando SB, Melquist S, Cannon A, Hutton M, Sletvold O, Saltvedt I, White LR, Lydersen S, Aasly J. Risk-reducing effect of education in Alzheimer's disease. International Journal of Geriatric Psychiatry. 23: 1156-62. PMID 18484674 DOI: 10.1002/Gps.2043  0.481
2008 Sando SB, Melquist S, Cannon A, Hutton ML, Sletvold O, Saltvedt I, White LR, Lydersen S, Aasly JO. APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway. Bmc Neurology. 8: 9. PMID 18416843 DOI: 10.1186/1471-2377-8-9  0.501
2008 Wider C, Melquist S, Hauf M, Solida A, Cobb SA, Kachergus JM, Gass J, Coon KD, Baker M, Cannon A, Stephan DA, Schorderet DF, Ghika J, Burkhard PR, Kapatos G, et al. Study of a Swiss dopa-responsive dystonia family with a deletion in GCH1: redefining DYT14 as DYT5. Neurology. 70: 1377-83. PMID 17804835 DOI: 10.1212/01.Wnl.0000275527.35752.C5  0.506
2007 Schymick JC, Yang Y, Andersen PM, Vonsattel JP, Greenway M, Momeni P, Elder J, Chiò A, Restagno G, Robberecht W, Dahlberg C, Mukherjee O, Goate A, Graff-Radford N, Caselli RJ, ... ... Cannon A, et al. Progranulin mutations and amyotrophic lateral sclerosis or amyotrophic lateral sclerosis-frontotemporal dementia phenotypes. Journal of Neurology, Neurosurgery, and Psychiatry. 78: 754-6. PMID 17371905 DOI: 10.1136/Jnnp.2006.109553  0.495
2007 Melquist S, Craig DW, Huentelman MJ, Crook R, Pearson JV, Baker M, Zismann VL, Gass J, Adamson J, Szelinger S, Corneveaux J, Cannon A, Coon KD, Lincoln S, Adler C, et al. Identification of a novel risk locus for progressive supranuclear palsy by a pooled genomewide scan of 500,288 single-nucleotide polymorphisms. American Journal of Human Genetics. 80: 769-78. PMID 17357082 DOI: 10.1086/513320  0.56
2007 Mesulam M, Johnson N, Krefft TA, Gass JM, Cannon AD, Adamson JL, Bigio EH, Weintraub S, Dickson DW, Hutton ML, Graff-Radford NR. Progranulin mutations in primary progressive aphasia: the PPA1 and PPA3 families. Archives of Neurology. 64: 43-7. PMID 17210807 DOI: 10.1001/Archneur.64.1.43  0.496
2007 Dächsel JC, Ross OA, Mata IF, Kachergus J, Toft M, Cannon A, Baker M, Adamson J, Hutton M, Dickson DW, Farrer MJ. Lrrk2 G2019S substitution in frontotemporal lobar degeneration with ubiquitin-immunoreactive neuronal inclusions. Acta Neuropathologica. 113: 601-6. PMID 17151837 DOI: 10.1007/S00401-006-0178-1  0.613
2006 Mackenzie IR, Baker M, Pickering-Brown S, Hsiung GY, Lindholm C, Dwosh E, Gass J, Cannon A, Rademakers R, Hutton M, Feldman HH. The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene. Brain : a Journal of Neurology. 129: 3081-90. PMID 17071926 DOI: 10.1093/Brain/Awl271  0.555
2006 Gass J, Cannon A, Mackenzie IR, Boeve B, Baker M, Adamson J, Crook R, Melquist S, Kuntz K, Petersen R, Josephs K, Pickering-Brown SM, Graff-Radford N, Uitti R, Dickson D, et al. Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Human Molecular Genetics. 15: 2988-3001. PMID 16950801 DOI: 10.1093/Hmg/Ddl241  0.575
2006 Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C, Snowden J, Adamson J, Sadovnick AD, Rollinson S, Cannon A, Dwosh E, Neary D, Melquist S, Richardson A, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature. 442: 916-9. PMID 16862116 DOI: 10.1038/Nature05016  0.628
2006 Cannon A, Baker M, Boeve B, Josephs K, Knopman D, Petersen R, Parisi J, Dickison D, Adamson J, Snowden J, Neary D, Mann D, Hutton M, Pickering-Brown SM. CHMP2B mutations are not a common cause of frontotemporal lobar degeneration. Neuroscience Letters. 398: 83-4. PMID 16431024 DOI: 10.1016/J.Neulet.2005.12.056  0.503
2006 Mackenzie IR, Baker M, West G, Woulfe J, Qadi N, Gass J, Cannon A, Adamson J, Feldman H, Lindholm C, Melquist S, Pettman R, Sadovnick AD, Dwosh E, Whiteheart SW, et al. A family with tau-negative frontotemporal dementia and neuronal intranuclear inclusions linked to chromosome 17. Brain : a Journal of Neurology. 129: 853-67. PMID 16401619 DOI: 10.1093/Brain/Awh724  0.535
2006 Melquist S, Huentelman MJ, Craig DW, Baker M, Crook R, Pearson JV, Zisman VL, Gass J, Adamson J, Szelinger S, Cournevaux JJ, Cannon A, Coon KD, Dickson DW, Stephan D, et al. P3-163: Identification of a novel risk gene for progressive supranuclear palsy by a genome-wide scan of 500,288 SNPs Alzheimer's & Dementia. 2: S422-S422. DOI: 10.1016/J.Jalz.2006.05.1431  0.527
Show low-probability matches.